Lewes Delaware based Samsara Therapeutics is raising $12,713,496.00 in New Equity Investment.
Lewes, DE – According to filings with the U.S. Securities and Exchange Commission, Samsara Therapeutics is raising $12,713,496.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jens Eckstein played a…